查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830915

2025年全球經導管二尖瓣市場報告

Transcatheter Mitral Valve Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，經導管二尖瓣市場呈現強勁成長勢頭，預計將從2024年的14.7億美元成長至2025年的16.1億美元，複合年成長率達9.5%。預測期內的成長主要歸因於微創心臟手術的日益普及、早期二尖瓣置換術（TMVR）器械臨床試驗成功率的提高、已開發地區醫院基礎設施的擴建、低收入國家風濕性心臟疾病患病率的上升以及介入心臟病專家專業培訓項目的增加。

預計未來幾年經導管二尖瓣市場將維持強勁成長，2029年市場規模將達到22.8億美元，年複合成長率（CAGR）為9.1%。預測期內的成長主要歸因於年輕患者對導管介入治療方案需求的不斷成長、新一代經導管二尖瓣置換術（TMVR）器械研發管線的不斷擴充、基於人工智慧成像技術的成像技術診斷日益受到重視、TMV器械監管核准的增加，以及導管二尖瓣手術中的應用。預測期內的關鍵趨勢包括：用於瓣膜評估的人工智慧成像技術的進步、用於增強生物相容性的先進材料塗層的開發、透過3D列印技術打造個人化TMV解決方案、輸送導管的靈活性和精確性方面的創新，以及將數位雙胞胎技術應用於手術規劃。

經導管二尖瓣置換術是一種微創裝置，旨在無需開胸手術即可修復或置換受損的二尖瓣。它透過一根細導管經靜脈或動脈插入心臟，從而改善血液流動並緩解二尖瓣疾病的相關症狀。這種方法尤其適用於傳統手術風險較高的患者。

經導管二尖瓣手術的主要產品類型包括經導管二尖瓣置換術和經導管二尖瓣瓣膜修復。經導管二尖瓣置換術術是將人工瓣膜或生物瓣膜經由導管（通常經由血管）植入心臟。此手術用於治療二尖瓣狹窄和二尖瓣逆流等疾病，並被包括醫院、門診手術中心和心臟導管室在內的多種醫療機構所採用。

美國不斷提高的關稅以及持續到2025年的貿易緊張局勢正對醫療設備行業產生重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所都在抵制價格上漲，這擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供經導管二尖瓣市場統計數據，包括全球市場規模、區域佔有率、主要競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和機遇，以及您在經導管二尖瓣行業取得成功所需的數據。本市場研究報告透過對產業現狀和未來發展趨勢的詳細分析，為您提供所需的一切資訊。

預計未來幾年，心臟病盛行率的上升將推動經導管二尖瓣置換術市場的成長。心臟病是一種損害心臟結構和功能的疾病，會降低心臟的泵血效率。這是因為與老齡化相關的心臟和血管劣化會增加二尖瓣逆流、心臟衰竭和心律不整等疾病的風險。經導管二尖瓣置換術透過修復或置換受損的二尖瓣來治療心臟，恢復心臟腔室之間的健康血流，改善心臟功能並緩解症狀。例如，根據美國疾病管制與預防中心（CDC）2024年10月的數據，心臟疾病是2022年最常見的心臟病類型，導致371,506人死亡。美國每年約有80.5萬人發生心臟病發作，其中首次發作（60.5萬人）幾乎是復發性發作（20萬人）的三倍。因此，心臟病盛行率的上升正在推動經導管二尖瓣置換術市場的擴張。

經導管二尖瓣置換術市場的主要參與者正致力於開發先進設備，例如經導管二尖瓣置換術（TMVR）系統，以拓展高風險或不適合手術患者的治療選擇。 TMVR系統是一種微創設備，它透過導管途徑將受損或病變的二尖瓣替換為人工瓣膜，無需進行開胸手術。例如，2025年5月，美國醫療設備公司雅培推出了獲得FDA核准的Tendyne。這款自膨脹式鎳鈦合金框架瓣膜有多種尺寸可供選擇，以適應不同的解剖結構，並且在植入過程中可以完全重新定位和取出。該系統透過胸部的小切口植入，實現了微創手術，通常只需約一個半小時​​即可完成。該系統旨在促進快速康復，大多數患者可在三天內出院，為沒有其他可行手術方案的高風險二尖瓣患者提供了突破性的治療選擇。

2024年4月，總部位於義大利的醫療技術投資公司TechWald Holding SpA收購了Valcare Medical Inc.，具體金額未揭露。此次收購旨在加強TechWald Holding在結構性心臟病器械市場的地位，並專注於經導管二尖瓣修復和置換領域。此次收購將增強公司在心血管領域的業務組合，加速Valcare器材的研發和商業化進程，並提升公司在微創心臟瓣膜治療領域的地位。 Valcare Medical Inc.總部位於以色列，專注於二尖瓣瓣膜閉鎖不全的微創經導管治療。

經導管二尖瓣市場包括經導管瓣環狀成形術器械、引導管、腱索修復器械以及輔助影像導航系統的銷售。該市場的價值為“出廠價”，即製造商或生產商銷售的商品價值，無論銷售對像是其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場商品的價值還包括製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球經導管二尖瓣置換術：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球經導管二尖瓣市場：成長率分析
  • 全球經導管二尖瓣市場表現：規模與成長，2019-2024年
  • 全球經導管二尖瓣市場預測：規模與成長，2024-2029年，2034年
  • 全球經導管二尖瓣置換術：潛在市場規模 (TAM)

第6章 市場細分

  • 全球經導管二尖瓣市場：依產品、性能及預測分類，2019-2024年、2024-2029年、2034年
  • 經導管二尖瓣置換術
  • 經導管二尖瓣瓣膜修復
  • 全球經導管二尖瓣市場：依適應症、表現及預測分類，2019-2024年、2024-2029年、2034年
  • 二尖瓣狹窄
  • 二尖瓣逆流
  • 全球經導管二尖瓣市場（依最終用戶、效能和預測分類），2019-2024年、2024-2029年、2034年
  • 醫院
  • 門診手術中心
  • 心臟導管實驗室
  • 全球經導管二尖瓣市場：經導管二尖瓣置換術細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 自膨脹閥
  • 球囊擴張閥
  • 全球經導管二尖瓣市場：經導管二尖瓣瓣膜修復細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 瓣環成形術
  • 弦線修復裝置
  • 邊緣到邊緣修復裝置

第7章 區域和國家分析

  • 全球經導管二尖瓣市場：區域表現及預測，2019-2024年、2024-2029年及2034年
  • 全球經導管二尖瓣市場：國家、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 經導管二尖瓣市場：競爭格局
  • 經導管二尖瓣市場：公司概況
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Inc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Meril Life Sciences Private Limited Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • MicroPort Scientific Corporation
  • Venus Medtech Inc.
  • Cardiac Dimensions Inc.
  • JenaValve Technology Inc.
  • Ancora Heart Inc
  • Peijia Medical Limited
  • Micro Interventional Devices Inc.
  • 4C Medical Technologies Inc.
  • NeoChord Inc.
  • Xeltis AG
  • Valcare Medical Inc.
  • Colibri Heart Valve LLC
  • MitrAssist Ltd.
  • HighLife SAS
  • Navigate Cardiac Structures Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年經導管二尖瓣市場：提供新機會的國家
  • 2029年經導管二尖瓣市場：新興細分市場機會
  • 2029年經導管二尖瓣市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37908

A transcatheter mitral valve is a minimally invasive device designed to repair or replace a damaged mitral valve without requiring open-heart surgery. It is delivered to the heart via a thin catheter inserted through a vein or artery, improving blood flow and alleviating symptoms associated with mitral valve disease. This approach is particularly beneficial for patients at high risk for traditional surgical procedures.

The primary product types of transcatheter mitral valves include transcatheter mitral valve replacement and transcatheter mitral valve repair. Transcatheter mitral valve replacement involves inserting a new artificial or biological mitral valve into the heart using a catheter, usually through a blood vessel. It is indicated for conditions such as mitral stenosis and mitral regurgitation and is utilized by various end users, including hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The transcatheter mitral valve market research report is one of a series of new reports from The Business Research Company that provides transcatheter mitral valve market statistics, including transcatheter mitral valve industry global market size, regional shares, competitors with a transcatheter mitral valve market share, detailed transcatheter mitral valve market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter mitral valve industry. The transcatheter mitral valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transcatheter mitral valve market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.61 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the increasing adoption of minimally invasive cardiac procedures, higher clinical trial success rates for early transcatheter mitral valve replacement (TMVR) devices, expansion of hospital infrastructure in developed regions, rising prevalence of rheumatic heart disease in low-income countries, and the growth of specialized training programs for interventional cardiologists.

The transcatheter mitral valve market size is expected to see strong growth in the next few years. It will grow to $2.28 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising demand for catheter-based treatment options among younger patients, an expanding pipeline of next-generation transcatheter mitral valve replacement (TMVR) devices, increased focus on early diagnosis using AI-based imaging, a growing number of regulatory approvals for TMV devices, and the adoption of real-time navigation and imaging technologies in transcatheter mitral valve procedures. Major trends in the forecast period include advancements in AI-powered imaging for valve assessment, development of advanced material coatings to enhance biocompatibility, creation of personalized TMV solutions through 3D printing, innovations in delivery catheter flexibility and precision, and integration of digital twin technology for procedural planning.

The rising prevalence of heart diseases is expected to drive the growth of the transcatheter mitral valve market in the coming years. Heart diseases are conditions that impair the structure or function of the heart, reducing its efficiency in pumping blood. This increasing prevalence is largely fueled by aging populations, as age-related deterioration of the heart and blood vessels heightens susceptibility to conditions such as mitral valve regurgitation, heart failure, and arrhythmias. Transcatheter mitral valves treat heart disease by repairing or replacing damaged mitral valves, restoring healthy blood flow between the heart's chambers, improving cardiac function, and alleviating symptoms. For example, according to the Centers for Disease Control and Prevention in October 2024, coronary heart disease was the most common type of heart disease in 2022, causing 371,506 deaths. Each year, roughly 805,000 people in the United States experience a heart attack, with first-time occurrences (605,000) happening about three times more often than recurrent cases (200,000). As a result, the growing prevalence of heart diseases is propelling the expansion of the transcatheter mitral valve market.

Key players in the transcatheter mitral valve market are concentrating on developing advanced devices, such as transcatheter mitral valve replacement (TMVR) systems, to broaden treatment options for high-risk or inoperable patients. TMVR systems are minimally invasive devices that replace a damaged or diseased mitral valve with an artificial valve via a catheter-based approach, eliminating the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, launched Tendyne, which received FDA approval. This self-expanding, nitinol-framed valve is available in multiple sizes to suit different anatomies and can be fully repositioned or retrieved during implantation. Delivered through a small chest incision, the system allows for a minimally invasive procedure typically completed in around 1.5 hours. Designed for quicker recovery, most patients can be discharged within three days, providing a transformative option for high-risk mitral valve patients without viable surgical alternatives.

In April 2024, TechWald Holding S.p.A., an Italy-based medical technology investment company, acquired Valcare Medical Inc. for an undisclosed sum. This acquisition aims to strengthen TechWald Holding's presence in the structural heart device market, focusing on transcatheter mitral valve repair and replacement. The deal enhances its cardiovascular portfolio, accelerates Valcare's device development and commercialization, and bolsters its position in minimally invasive heart valve therapies. Valcare Medical Inc., based in Israel, specializes in minimally invasive transcatheter treatments for mitral regurgitation.

Major players in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.

North America was the largest region in the transcatheter mitral valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transcatheter mitral valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transcatheter mitral valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transcatheter mitral valve market consists of sales of transcatheter annuloplasty devices, guiding catheters, chordal repair devices, and adjunctive imaging and navigation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transcatheter Mitral Valve Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transcatheter mitral valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transcatheter mitral valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcatheter mitral valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Transcatheter Mitral Valve Replacement; Transcatheter Mitral Valve Repair
  • 2) By Indication: Mitral Stenosis; Mitral Regurgitation
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Catheterization Laboratories
  • Subsegments:
  • 1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves; Balloon-Expandable Valves
  • 2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices; Chordal Repair Devices; Edge-To-Edge Repair Devices
  • Companies Mentioned: Abbott Laboratories; Medtronic Inc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Meril Life Sciences Private Limited; MicroPort Scientific Corporation; Venus Medtech Inc.; Cardiac Dimensions Inc.; JenaValve Technology Inc.; Ancora Heart Inc; Peijia Medical Limited; Micro Interventional Devices Inc.; 4C Medical Technologies Inc.; NeoChord Inc.; Xeltis AG; Valcare Medical Inc.; Colibri Heart Valve LLC; MitrAssist Ltd.; HighLife SAS; Navigate Cardiac Structures Inc.; Cardiovalve Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transcatheter Mitral Valve Market Characteristics

3. Transcatheter Mitral Valve Market Trends And Strategies

4. Transcatheter Mitral Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transcatheter Mitral Valve Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transcatheter Mitral Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transcatheter Mitral Valve Market Growth Rate Analysis
  • 5.4. Global Transcatheter Mitral Valve Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transcatheter Mitral Valve Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transcatheter Mitral Valve Total Addressable Market (TAM)

6. Transcatheter Mitral Valve Market Segmentation

  • 6.1. Global Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Mitral Valve Replacement
  • Transcatheter Mitral Valve Repair
  • 6.2. Global Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mitral Stenosis
  • Mitral Regurgitation
  • 6.3. Global Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • 6.4. Global Transcatheter Mitral Valve Market, Sub-Segmentation Of Transcatheter Mitral Valve Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Expanding Valves
  • Balloon-Expandable Valves
  • 6.5. Global Transcatheter Mitral Valve Market, Sub-Segmentation Of Transcatheter Mitral Valve Repair, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Annuloplasty Devices
  • Chordal Repair Devices
  • Edge-To-Edge Repair Devices

7. Transcatheter Mitral Valve Market Regional And Country Analysis

  • 7.1. Global Transcatheter Mitral Valve Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transcatheter Mitral Valve Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transcatheter Mitral Valve Market

  • 8.1. Asia-Pacific Transcatheter Mitral Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transcatheter Mitral Valve Market

  • 9.1. China Transcatheter Mitral Valve Market Overview
  • 9.2. China Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transcatheter Mitral Valve Market

  • 10.1. India Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transcatheter Mitral Valve Market

  • 11.1. Japan Transcatheter Mitral Valve Market Overview
  • 11.2. Japan Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transcatheter Mitral Valve Market

  • 12.1. Australia Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transcatheter Mitral Valve Market

  • 13.1. Indonesia Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transcatheter Mitral Valve Market

  • 14.1. South Korea Transcatheter Mitral Valve Market Overview
  • 14.2. South Korea Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transcatheter Mitral Valve Market

  • 15.1. Western Europe Transcatheter Mitral Valve Market Overview
  • 15.2. Western Europe Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transcatheter Mitral Valve Market

  • 16.1. UK Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transcatheter Mitral Valve Market

  • 17.1. Germany Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transcatheter Mitral Valve Market

  • 18.1. France Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transcatheter Mitral Valve Market

  • 19.1. Italy Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transcatheter Mitral Valve Market

  • 20.1. Spain Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transcatheter Mitral Valve Market

  • 21.1. Eastern Europe Transcatheter Mitral Valve Market Overview
  • 21.2. Eastern Europe Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transcatheter Mitral Valve Market

  • 22.1. Russia Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transcatheter Mitral Valve Market

  • 23.1. North America Transcatheter Mitral Valve Market Overview
  • 23.2. North America Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transcatheter Mitral Valve Market

  • 24.1. USA Transcatheter Mitral Valve Market Overview
  • 24.2. USA Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transcatheter Mitral Valve Market

  • 25.1. Canada Transcatheter Mitral Valve Market Overview
  • 25.2. Canada Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transcatheter Mitral Valve Market

  • 26.1. South America Transcatheter Mitral Valve Market Overview
  • 26.2. South America Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transcatheter Mitral Valve Market

  • 27.1. Brazil Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transcatheter Mitral Valve Market

  • 28.1. Middle East Transcatheter Mitral Valve Market Overview
  • 28.2. Middle East Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transcatheter Mitral Valve Market

  • 29.1. Africa Transcatheter Mitral Valve Market Overview
  • 29.2. Africa Transcatheter Mitral Valve Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transcatheter Mitral Valve Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transcatheter Mitral Valve Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transcatheter Mitral Valve Market Competitive Landscape And Company Profiles

  • 30.1. Transcatheter Mitral Valve Market Competitive Landscape
  • 30.2. Transcatheter Mitral Valve Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Meril Life Sciences Private Limited Overview, Products and Services, Strategy and Financial Analysis

31. Transcatheter Mitral Valve Market Other Major And Innovative Companies

  • 31.1. MicroPort Scientific Corporation
  • 31.2. Venus Medtech Inc.
  • 31.3. Cardiac Dimensions Inc.
  • 31.4. JenaValve Technology Inc.
  • 31.5. Ancora Heart Inc
  • 31.6. Peijia Medical Limited
  • 31.7. Micro Interventional Devices Inc.
  • 31.8. 4C Medical Technologies Inc.
  • 31.9. NeoChord Inc.
  • 31.10. Xeltis AG
  • 31.11. Valcare Medical Inc.
  • 31.12. Colibri Heart Valve LLC
  • 31.13. MitrAssist Ltd.
  • 31.14. HighLife SAS
  • 31.15. Navigate Cardiac Structures Inc.

32. Global Transcatheter Mitral Valve Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transcatheter Mitral Valve Market

34. Recent Developments In The Transcatheter Mitral Valve Market

35. Transcatheter Mitral Valve Market High Potential Countries, Segments and Strategies

  • 35.1 Transcatheter Mitral Valve Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transcatheter Mitral Valve Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transcatheter Mitral Valve Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer